Pregabalin (Lyrica) for the Treatment of Vulvodynia: A Randomized, Double-Blinded, Placebo-Controlled Cross-Over Study.
Phase of Trial: Phase II
Latest Information Update: 19 May 2017
At a glance
- Drugs Pregabalin (Primary)
- Indications Vulvodynia
- Focus Therapeutic Use
- 09 Jan 2013 Planned end date changed from 1 Jun 2012 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 24 Feb 2012 Planned end date changed from 1 Apr 2010 to 1 Jun 2012 as reported by ClinicalTrials.gov.
- 24 Feb 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.